| Original language | English (US) |
|---|---|
| Pages (from-to) | 954-956 |
| Number of pages | 3 |
| Journal | Annals of Oncology |
| Volume | 32 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2021 |
ASJC Scopus subject areas
- Hematology
- Oncology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Annals of Oncology, Vol. 32, No. 8, 08.2021, p. 954-956.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Important news on nutritional support in cancer patients – but some EFFORT is still ahead
T2 - Referring to Bargetzi et al., ‘Nutritional support during hospital stay reduces mortality in patients with different types of cancer: a secondary analysis of a prospective randomized trial’
AU - Arends, J.
AU - Roeland, E. J.
AU - Baracos, V. E.
N1 - Funding Information: None declared. JA has served on advisory boards for Baxter, Helsinn and Nutricia. He has received honoraria from Berg-Apotheke, B. Braun, Falk, Fresenius Kabi and Nutricia. EJR has served as a consultant for Asahi Kasei Pharmaceuticals, DRG Consulting, Napo Pharmaceuticals, American Imaging Management. Additionally, he has served on recent advisory boards for Heron Pharmaceuticals, Pfizer, Vector Oncology, and Helsinn Pharmaceuticals. He is also a member of the data safety committees for Oragenics, Inc, Galera Pharmaceuticals, and Enzychem Lifesciences Pharmaceutical Company. VEB has served on advisory boards for Baxter Healthcare, Pfizer, Nestle Health Science, Aurin Biopharma.
PY - 2021/8
Y1 - 2021/8
UR - http://www.scopus.com/inward/record.url?scp=85109926705&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109926705&partnerID=8YFLogxK
U2 - 10.1016/j.annonc.2021.06.020
DO - 10.1016/j.annonc.2021.06.020
M3 - Editorial
C2 - 34272040
AN - SCOPUS:85109926705
SN - 0923-7534
VL - 32
SP - 954
EP - 956
JO - Annals of Oncology
JF - Annals of Oncology
IS - 8
ER -